Humana Inc. Files 8-K on Financials

Ticker: HUM · Form: 8-K · Filed: 2025-04-30T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: HUM

TL;DR

Humana dropped its 8-K, check the financials.

AI Summary

Humana Inc. filed an 8-K on April 30, 2025, reporting on its financial condition and results of operations. The filing includes financial statements and exhibits, with no specific dollar amounts or new material events detailed in the provided text.

Why It Matters

This filing provides an update on Humana's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Humana Inc.?

The primary purpose is to report on Humana Inc.'s Results of Operations and Financial Condition, as well as provide Regulation FD Disclosure and Financial Statements and Exhibits.

On what date was this 8-K filing reported?

The filing was reported on April 30, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive office is located at 500 West Main Street, Louisville, KY 40202.

What is Humana Inc.'s IRS Employer Identification Number?

Humana Inc.'s IRS Employer Identification Number is 61-0647538.

In which state was Humana Inc. incorporated?

Humana Inc. was incorporated in Delaware.

From the Filing

0000049071-25-000021.txt : 20250430 0000049071-25-000021.hdr.sgml : 20250430 20250430060550 ACCESSION NUMBER: 0000049071-25-000021 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250430 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250430 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 25890659 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20250430.htm 8-K hum-20250430 0000049071 false 0000049071 2025-04-30 2025-04-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K                  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  April 30, 2025 (April 30, 2025) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 1-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street Louisville , KY 40202 (Address of principal executive offices, including zip code) 502 - 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 2.02    Results of Operations and Financial Condition. Item 7.01    Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended March 31, 2025, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company’s website at www.humana.com . A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated

View on Read The Filing